Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
University of Washington
University of Washington
National Cancer Institute (NCI)
University Hospital Heidelberg
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center